| Page 1811 | Kisaco Research
 

Lewis Gruber

CEO
SIWA Therapeutics, Inc.

Lewis Gruber is Chief Executive Officer and a founder of SIWA Therapeutics, Inc. (“SIWA”). SIWA is a pre-clinical stage biopharmaceutical company with a first-in-class humanized monoclonal antibody (“mAb”) that binds to a SIWA-identified advanced glycation endproduct target antigen on senescent cells (“SCs”) and removes them. SCs accumulate with aging or exposure to stress and have a causative role in age-related dysfunction and degenerative diseases including.

Lewis Gruber

CEO
SIWA Therapeutics, Inc.

Lewis Gruber

CEO
SIWA Therapeutics, Inc.

Lewis Gruber is Chief Executive Officer and a founder of SIWA Therapeutics, Inc. (“SIWA”). SIWA is a pre-clinical stage biopharmaceutical company with a first-in-class humanized monoclonal antibody (“mAb”) that binds to a SIWA-identified advanced glycation endproduct target antigen on senescent cells (“SCs”) and removes them. SCs accumulate with aging or exposure to stress and have a causative role in age-related dysfunction and degenerative diseases including. by way of example, many cancers, and neurodegenerative diseases such as Parkinson’s, ALS, and Alzheimer’s Disease, SIWA has the complete sequence of SIWA 318H, which provides the basis for senescent cell clearance in any mammalian species. Prior to founding SIWA, Mr. Gruber was a founder of Arryx, Inc., and served as its CEO from 2000 through 2005 (acquired by a publicly-held company).  While Mr. Gruber was at Arryx, it received numerous awards including ones for World Economic Forum Technology Pioneer (2005) and Red Herring Top 100 Innovator for 2004.  Prior to Arryx, he was a founder of Hyseq, Inc, a publicly-held genomics company (subsequently merged). He served as Hyseq’s CEO from 1994 through 2000. While CEO, Hyseq completed the largest IPO of a biotechnology company in 1997 (underwritten by Salomon Smith Barney and others) and obtained collaborations for Hyseq totaling over $10 million. The technology was sold to Beijing Genomics Institute. 

 

Alessio Dantino

Founder and CEO
Forward Fooding

Alessio Dantino

Founder and CEO
Forward Fooding

Alessio Dantino

Founder and CEO
Forward Fooding
Interview with Geoff Tate, CEO, FlexLogix
Best In Show Finalists - USA 2018
 
Autonomous Vehicle Hardware Summit
27 Mar 2019
Silicon Valley, CA
The Autonomous Vehicle Hardware Summit is the first and only conference focusing solely on architectural and engineering challenges for silicon, sensors and systems in autonomous vehicles. The automotive electronics industry will grow to $280 billion by 2020, and will likely look very different, as new entrants such as NVIDIA enter the space with new autonomous driving solutions and advanced-node AI accelerators. Many new entrants have little to no experience of the automotive industry’s stringent functional safety requirements, while testing and simulation methodologies for semiconductor products are meeting with skepticism from auto OEMs and their suppliers.To control the automated driving value chain a knowledge of hardware is crucial – the hardware architectures of Level 3, 4 & 5 AVs, often termed ‘super computers on wheels’, will be fundamental to the ultimate effectiveness and cost of the vehicle, and the overall quality of the user experience. The AV Hardware Summit will bring together 150+ tech and auto leaders to help overcome these challenges and pave the way for the next generation of driverless cars.